Form 4 for JNJ Johnson & Johnson
Accepted 2022-11-23 16:44:21 ET · period of report 2022-11-22 · accession 0001225208-22-011890 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-23 16:44 | 2022-11-22 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $72.54 | +76.9K | 203.4K | +61% | +$5.58M |
| D | 2022-11-23 16:44 | 2022-11-22 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | S - Sale+OE | $176.78 | -76.9K | 126.5K | -38% | -$13.60M |
| D | 2022-11-23 16:44 | 2022-11-22 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $0.00 | -76.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-22 | M | A | 76,923 | $72.54 | 203,379.00 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-22 | S | D | 76,923 | $176.78 | 126,456.00 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $176.525 to $177.190. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Employee Stock Options (Right to Buy) | 2022-11-22 | M | D | 76,923 | $0.00 | 0 | D | $72.54 · 2016-01-17 to 2023-01-13 | 76,923 Common Stock |